Lineage Plasticity and Immune Cell Heterogeneity Are Coordinately Dysregulated Through Changes in FOXA1 Expression in Bladder Cancers with Squamous Differentiation

AFFECTION_STATUS - Case control status of the subject for Bladder Urothelial Cancer; All subjects are cancer patients. (phv00508971.v1.p1)
DIFFERENTIATION_TYPE - Urothelial carcinoma with squamous differentiation or not otherwise specified (phv00525491.v1.p1)
HISTOLOGICAL_SUBTYPE - Cancer subtype (phv00508978.v1.p1)
HISTOLOGICAL_TYPE - Cancer type (phv00508977.v1.p1)
IS_TUMOR - Is sample derived from tumor (phv00508975.v1.p1)

ANALYTE_TYPE - Analyte type (phv00508974.v1.p1)
BODY_SITE - Anatomical site from which sample was collected (phv00508973.v1.p1)
CONSENT - Consent group as determined by DAC (phv00508965.v1.p1)
SAMPLE_ID - Sample ID (phv00508972.v1.p1)
SAMPLE_ID - Sample ID (phv00508968.v1.p1)
SAMPLE_TYPE - Sample type collected (phv00508976.v1.p1)
SEQUENCING_PANEL - Exome capture panel (phv00508979.v1.p1)
SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00525846.v1.p1)
SUBJECT_ID - Subject ID (phv00508964.v1.p1)
SUBJECT_ID - Subject ID (phv00508969.v1.p1)
SUBJECT_ID - Subject ID (phv00508967.v1.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00525845.v1.p1)